Green A, et al. Effect of ocrelizumab versus interferon β-1a on retinal thinning and association with brain volume loss in the OPERA I and OPERA II Phase III trials in relapsing multiple sclerosis. Abstract 92. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Primaire auto-immuun hemolytische anemie geassocieerd met ischemisch CVA
feb 2024 | Benigne hematologie, Neuro-vasculair